18F-FDG PET as a routine posttreatment surveillance tool in oral and oropharyngeal squamous cell carcinoma: a prospective study.
about
Follow-up in Head and Neck Cancer: Do More Does It Mean Do Better? A Systematic Review and Our Proposal Based on Our ExperienceMultiple primary malignant tumors of upper gastrointestinal tract: a novel role of 18F-FDG PET/CT.Surveillance radiologic imaging after treatment of oropharyngeal cancer: a review.PET/CT in Radiotherapy Planning for Head and Neck CancerEvaluating the potential role of PET/CT in the posttreatment surveillance of head and neck cancer(18)F-FDG PET/CT surveillance at 3-6 and 12 months for detection of recurrence and second primary cancer in patients with head and neck squamous cell carcinoma.Efficacy of qualitative response assessment interpretation criteria at 18F-FDG PET-CT for predicting outcome in locally advanced cervical carcinoma treated with chemoradiotherapy.Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis.Post-therapeutic surveillance schedule for oral cancer: is there agreement?Role of (18)F-FDG PET-CT in head and neck squamous cell carcinomaPET-CT and the detection of the asymptomatic recurrence or second primary lesions in the treated head and neck cancer patient.Functional imaging in radiation therapy planning for head and neck cancer.Prognostic value of 18F-FDG uptake by regional lymph nodes on pretreatment PET/CT in patients with resectable colorectal cancer.AHNS Series--Do you know your guidelines? Guideline recommended follow-up and surveillance of head and neck cancer survivors.Present and future role of FDG-PET/CT imaging in the management of head and neck carcinoma.Potential Role of PET/MRI for Imaging Metastatic Lymph Nodes in Head and Neck Cancer.Positron emission tomography/computed tomography after primary transoral robotic surgery for oropharyngeal squamous cell carcinoma.The value of follow-up FDG-PET/CT in the management and prognosis of patients with HPV-positive oropharyngeal squamous cell carcinoma.Head and neck PET/CT therapy response interpretation criteria (Hopkins criteria) - external validation studyWhen should surveillance imaging be performed after treatment for head and neck cancer?Impact of positron emission tomography/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrence.AHNS Series: Do you know your guidelines? Evidence-based management of oral cavity cancers.Response evaluation after chemoradiotherapy for advanced staged oropharyngeal squamous cell carcinoma: a nationwide survey in the Netherlands.Qualitative interpretation of PET scans using a Likert scale to assess neck node response to radiotherapy in head and neck cancer.Usefulness of esophagogastroduodenoscopy and 18F-fluorodeoxyglucose positron-emission tomography in detecting synchronous multiple primary cancers with oral cancer.Diagnostic performance of FDG PET/CT to detect subclinical HNSCC recurrence 6 months after the end of treatment.FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.Detection of subclinical recurrence or second primary cancer using (18) F-FDG PET/CT in patients treated curatively for head and neck squamous cell carcinoma.The value of (18) F-FDG-PET/CT imaging in oral cavity cancer patients following surgical reconstruction.Prognostic value of pretreatment ¹⁸F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma.
P2860
Q28080298-5C66C0EA-4DD4-4E53-982E-CF4E94BCA26DQ34073642-017A86C6-550D-47DE-B819-49E58ACDAD1FQ35174896-21362495-302D-44FB-B704-C8C7770E6DE3Q36455944-71038A27-90CD-4BDA-8635-4ADECC46C6EEQ37146255-386FF262-708E-4264-9A37-9B0B5C150E3EQ37385263-42C705C9-A945-4523-BB19-11532E35239BQ37662679-A3C75C16-B998-4473-8391-7ED4C2A931A0Q37919750-CCF82310-7B03-41DB-9206-3A307993EDB7Q38039886-A959E467-FF06-45D9-A5A5-F9D9681A4B25Q38101933-D36FCDC4-D2A8-4407-BAA8-532E0B960122Q38118623-73852714-15A9-4F69-9EEB-E4A1932181B9Q38177809-615119B4-A7FE-4FDE-A326-1B7BD323A48EQ38436640-A3168C97-EFC9-42F3-A00C-6A0D2429D791Q38444526-0451DEBB-E705-4888-8E29-E7DF9343957CQ38617866-956736A7-56BF-48BC-B848-53CFBBC3873EQ38830809-1DAEAA48-68AC-4FC3-9154-9E086E3E1885Q39168304-085D5A4A-75CA-4EA6-995F-41204DA76F65Q40107513-44BD883B-261C-46EB-A41D-A90412A3EFE9Q41180610-4AC72A2F-3FB9-4FFA-BC27-A33533EE227BQ46372061-0FD0C335-50C4-46E4-84E3-BF9F39ACB576Q46593013-40BAADB2-E7E0-4FE8-BE7A-0FF92E3BF723Q46796923-FFB2DD09-43C1-4707-9578-95EC8C73A202Q47793026-F5390AA3-1911-4A3C-A0CF-3FD2DC150534Q48125466-A6409A52-972D-4A21-B1E6-40B334CDA4EBQ50255383-EB19BAFB-F639-4298-82D9-893FFF4E5FD6Q50638854-8AC373B3-5A5D-447E-85C8-475A0DBAAF58Q52929956-79C55C64-184C-41FE-9B33-D42A004F7C9FQ53020937-A9E3F54F-A5E3-4708-B000-06232F3B90DDQ53258296-68B46CCB-8769-4118-A74E-3475F5790AB7Q54298531-01024B0C-8FD2-42C4-B773-5DB5E1A0EDAB
P2860
18F-FDG PET as a routine posttreatment surveillance tool in oral and oropharyngeal squamous cell carcinoma: a prospective study.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
18F-FDG PET as a routine postt ...... arcinoma: a prospective study.
@en
18F-FDG PET as a routine postt ...... arcinoma: a prospective study.
@nl
type
label
18F-FDG PET as a routine postt ...... arcinoma: a prospective study.
@en
18F-FDG PET as a routine postt ...... arcinoma: a prospective study.
@nl
prefLabel
18F-FDG PET as a routine postt ...... arcinoma: a prospective study.
@en
18F-FDG PET as a routine postt ...... arcinoma: a prospective study.
@nl
P2093
P1476
18F-FDG PET as a routine postt ...... carcinoma: a prospective study
@en
P2093
Christiaan A Krabbe
Hans Balink
Jan G de Visscher
Jan L Roodenburg
Pieter U Dijkstra
P304
P356
10.2967/JNUMED.109.065300
P407
P577
2009-11-12T00:00:00Z